Atypical disease after Bordetella pertussis respiratory infection of mice with targeted disruptions of interferon-gamma receptor or immunoglobulin mu chain genes
about
The O antigen enables Bordetella parapertussis to avoid Bordetella pertussis-induced immunityRoads to the development of improved pertussis vaccines paved by immunologyThe route less taken: pulmonary models of enteric Gram-negative infectionWaning and aging of cellular immunity to Bordetella pertussisReview of the neutrophil response to Bordetella pertussis infection.Suppression of serum antibody responses by pertussis toxin after respiratory tract colonization by Bordetella pertussis and identification of an immunodominant lipoproteinComparative gene expression profiling in two congenic mouse strains following Bordetella pertussis infection.O antigen allows B. parapertussis to evade B. pertussis vaccine-induced immunity by blocking binding and functions of cross-reactive antibodies.T- and B-cell-mediated protection induced by novel, live attenuated pertussis vaccine in mice. Cross protection against parapertussis.Acellular pertussis vaccine protects against exacerbation of allergic asthma due to Bordetella pertussis in a murine model.A murine model in which protection correlates with pertussis vaccine efficacy in children reveals complementary roles for humoral and cell-mediated immunity in protection against Bordetella pertussis.Genetic control of Bordetella pertussis infection: identification of susceptibility loci using recombinant congenic strains of miceBiologic functions of the IFN-gamma receptors.Protective effects of pertussis immunoglobulin (P-IGIV) in the aerosol challenge modelA role for TLR4 in Clostridium difficile infection and the recognition of surface layer proteins.Fasciola hepatica suppresses a protective Th1 response against Bordetella pertussis.Importance of B cells, but not specific antibodies, in primary and secondary protective immunity to the intracellular bacterium Francisella tularensis live vaccine strainMutants of Escherichia coli heat-labile toxin act as effective mucosal adjuvants for nasal delivery of an acellular pertussis vaccine: differential effects of the nontoxic AB complex and enzyme activity on Th1 and Th2 cells.Igh-6(-/-) (B-cell-deficient) mice fail to mount solid acquired resistance to oral challenge with virulent Salmonella enterica serovar typhimurium and show impaired Th1 T-cell responses to Salmonella antigens.A regulatory role for interleukin 4 in differential inflammatory responses in the lung following infection of mice primed with Th1- or Th2-inducing pertussis vaccines.Whole-cell but not acellular pertussis vaccines induce convulsive activity in mice: evidence of a role for toxin-induced interleukin-1beta in a new murine model for analysis of neuronal side effects of vaccination.Quantitative priming with inactivated pertussis toxoid vaccine in the aerosol challenge model.B-cell-deficient mice show an exacerbated inflammatory response in a model of Chlamydophila abortus infection.c-di-GMP enhances protective innate immunity in a murine model of pertussisInterleukin-1 receptor signaling is required to overcome the effects of pertussis toxin and for efficient infection- or vaccination-induced immunity against Bordetella pertussis.gammadelta T cells regulate the early inflammatory response to bordetella pertussis infection in the murine respiratory tract.Do early childhood immunizations influence the development of atopy and do they cause allergic reactions?Immune responses to pertussis antigens in infants and toddlers after immunization with multicomponent acellular pertussis vaccine.Host genetics of Bordetella pertussis infection in mice: significance of Toll-like receptor 4 in genetic susceptibility and pathobiology.Maternal immunity provides protection against pertussis in newborn pigletsRelative contribution of Th1 and Th17 cells in adaptive immunity to Bordetella pertussis: towards the rational design of an improved acellular pertussis vaccine.A live, attenuated Bordetella pertussis vaccine provides long-term protection against virulent challenge in a murine model.Loss of multi-epitope specificity in memory CD4(+) T cell responses to B. pertussis with age.T-cell immune response assessment as a complement to serology and intranasal protection assays in determining the protective immunity induced by acellular pertussis vaccines in mice.Effect of different forms of adenylate cyclase toxin of Bordetella pertussis on protection afforded by an acellular pertussis vaccine in a murine model.Lung response to Bordetella pertussis infection in mice identified by gene-expression profilingPathogen-specific T regulatory 1 cells induced in the respiratory tract by a bacterial molecule that stimulates interleukin 10 production by dendritic cells: a novel strategy for evasion of protective T helper type 1 responses by Bordetella pertussiReceptor-mediated immunoglobulin G transport across mucosal barriers in adult life: functional expression of FcRn in the mammalian lung.Protective immunity to Bordetella pertussis requires both B cells and CD4(+) T cells for key functions other than specific antibody productionBordetella pertussis expresses a functional type III secretion system that subverts protective innate and adaptive immune responses.
P2860
Q24672570-9036E6FF-7A23-4918-8082-034215033775Q26782939-2DB7113D-9EBC-4197-830D-857E2E20FD33Q27691303-422EAA82-D31A-4083-BEA3-1808087680D4Q28080731-E5BD0B0E-3ABE-4357-A898-3E11DA0F8BEEQ30278579-06F1FEC3-C794-4B87-BCEB-2C8B5DA51608Q30449521-403AC0CB-1B09-4BC7-8125-56F9384719A0Q33302556-DAD90957-E425-48D9-9358-36E7DB298D90Q33502706-2476EF06-4096-4508-80BE-B0A5EA160360Q33564283-AD42F489-67B0-4B8A-ACA2-41389C617089Q33716587-5AA394B9-AF18-422D-8023-8F6ADAD1AF4DQ33750257-9BA53467-799F-49E7-BC5E-2EE5B905258BQ33796054-5DF7BF2C-7B7F-4B96-9112-1173854795C7Q33846008-FA943828-C837-4870-8856-760CBB45E1C5Q33866775-E4437077-12F7-43EF-8B08-50107E376188Q33954369-4AD72082-E68F-4CAA-88D9-357674100D85Q34002181-6CC8A82B-9258-4D9A-A8A1-EB3F03A7D7DBQ34002527-F39ADA77-8B71-4977-8848-24808854B1FEQ34002672-EB61E487-6FC2-4189-9F48-91E517D5C113Q34002939-8C8FB801-6A44-4BA2-A495-D83D7E530EABQ34003563-9B0DD7B8-9E5B-4B4D-A07E-A4FE02296BBDQ34008022-87635898-72A3-42ED-A642-500E1BC5A678Q34129001-B303BDC0-BBC5-4001-BDB2-18E8EE416BABQ34259955-245577DB-5473-4F0E-A8A5-D63669866876Q34343647-292DCC7C-0391-463D-A515-DDE4DB3F1BA6Q34484529-CD49934F-D5B0-47C2-89E1-2FCBD9690CA3Q34491729-DE78FD41-952D-4547-96FD-D077420814D9Q34532620-059B4E98-7B72-4849-9E5A-FCCAE99F895CQ34593062-E9D274DC-CF81-4583-A05D-51DEBB3F5303Q34601854-8E61B693-B5E3-47BE-96D9-4D63AAEA097DQ34601948-2AA9CC3F-19C0-42D6-A2DE-94BB9B7ABB86Q34671882-A116D46B-67CC-442A-B1EF-9422DC70465CQ34738678-213E7B9A-E600-4FC6-9A49-1484211FDE6FQ35082532-04A659A5-6D35-4B4D-9B93-4DFAC022F564Q35140321-BFB66DAD-DFDF-470F-8AD7-59864E90CD07Q35220336-01567D0B-AF91-4912-9F36-F8F09641B795Q35881038-0AB69BA6-0D19-433F-A870-5C653C1B8DE6Q36369855-A089E8EA-2E83-4B89-B058-754C62182762Q36370858-91623216-1BAE-4028-B956-60A5D4E71641Q36404631-8546E196-4850-48C4-9AB8-13EC09711994Q36483610-EA6DA1ED-8F88-4702-A5E1-7DA73C700350
P2860
Atypical disease after Bordetella pertussis respiratory infection of mice with targeted disruptions of interferon-gamma receptor or immunoglobulin mu chain genes
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh
1997年學術文章
@zh-hant
name
Atypical disease after Bordete ...... immunoglobulin mu chain genes
@ast
Atypical disease after Bordete ...... immunoglobulin mu chain genes
@en
type
label
Atypical disease after Bordete ...... immunoglobulin mu chain genes
@ast
Atypical disease after Bordete ...... immunoglobulin mu chain genes
@en
prefLabel
Atypical disease after Bordete ...... immunoglobulin mu chain genes
@ast
Atypical disease after Bordete ...... immunoglobulin mu chain genes
@en
P2093
P2860
P356
P1476
Atypical disease after Bordete ...... immunoglobulin mu chain genes
@en
P2093
P2860
P304
P356
10.1084/JEM.186.11.1843
P407
P577
1997-12-01T00:00:00Z